
WOOJUNG BIO, Inc. — Investor Relations & Filings
WOOJUNG BIO, Inc. is a bio-infrastructure company providing an integrated platform for research and development in the life sciences. The company's core activities are structured around three main pillars. First, it offers comprehensive pre-clinical Contract Research Organization (CRO) services, including efficacy studies, safety evaluations, and pharmaceutical analysis, utilizing its advanced animal laboratory facilities. Second, it specializes in the engineering and construction of modernized research environments, offering complete solutions for building and managing smart laboratories, animal rooms, and GMP-compliant clean rooms. Third, through its 'WOOJUNG BIO Cluster' open innovation platform, it provides R&D infrastructure, incubation, and acceleration support for bio-ventures and startups, aiming to foster the new drug development ecosystem and help transform innovative ideas into therapies.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 전환가액의조정 | 2026-06-09 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-06-09 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-06-04 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-06-04 | Korean | |
| 대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)] | 2026-06-01 | Korean | |
| 주주명부폐쇄기간또는기준일설정 | 2026-05-29 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 48009947 | 전환가액의조정 | 2026-06-09 | Korean | ||
| 48009015 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-06-09 | Korean | ||
| 47962292 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-06-04 | Korean | ||
| 47961890 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-06-04 | Korean | ||
| 47910911 | 대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)] | 2026-06-01 | Korean | ||
| 47878198 | 주주명부폐쇄기간또는기준일설정 | 2026-05-29 | Korean | ||
| 47878193 | 주주총회소집결의 | 2026-05-29 | Korean | ||
| 46349700 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 33225312 | [기재정정]주식등의대량보유상황보고서(일반) | 2026-04-03 | Korean | ||
| 33225292 | 주식등의대량보유상황보고서(일반) | 2026-04-03 | Korean | ||
| 33118819 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33117071 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-31 | Korean | ||
| 33116956 | 대표이사변경 | 2026-03-31 | Korean | ||
| 33086582 | 증권발행결과(자율공시) | 2026-03-30 | Korean | ||
| 33086213 | [기재정정]주요사항보고서(전환사채권발행결정) | 2026-03-30 | Korean | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Whitehawk Therapeutics, Inc.
A preclinical oncology company developing advanced antibody…
|
WHWK | US | Professional, scientific and te… |
|
WuXi AppTec Co., Ltd.
Global CRDMO enabling pharma and life sciences to accelerat…
|
2359 | CN | Professional, scientific and te… |
|
Xceleron Inc.
Specialist provider of ultra-sensitive bioanalytical servic…
|
— | CA | Professional, scientific and te… |
|
XEROS TECHNOLOGY GROUP PLC
Develops and licenses polymer-based solutions that reduce i…
|
XSG | GB | Professional, scientific and te… |
|
Xilio Therapeutics, Inc.
A clinical-stage biotech developing tumor-activated immuno-…
|
XLO | US | Professional, scientific and te… |
|
XINJIANG BAI HUA CUN PHARMA TECH CO.,LTD
Pharmaceutical R&D and CRO services for drug discovery and …
|
600721 | CN | Professional, scientific and te… |
|
Xintela AB
Biomedical company developing stem cell therapies for regen…
|
XINT | SE | Professional, scientific and te… |
|
Xlife Sciences AG
Develops and commercializes early-stage life sciences resea…
|
XLS | CH | Professional, scientific and te… |
|
XtalPi Holdings Limited
Accelerates molecular R&D using AI, quantum physics, and ro…
|
2228 | KY | Professional, scientific and te… |
|
Y-Biologics, Inc
Develops antibody-based therapeutics for cancer, focusing o…
|
338840 | KR | Professional, scientific and te… |
WOOJUNG BIO, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17455/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17455 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17455 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17455 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17455}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for WOOJUNG BIO, Inc. (id: 17455)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.